Dana-Farber Cancer Institute researchers have identified factors that determine whether donor lymphocyte infusion (DLI), a standard therapy for patients with acute myeloid leukemia (AML ...

The current treatment for relapsed AML, donor lymphocyte infusion (DLI)-a therapy involving donor immune cells-has a 5-year survival rate of only 24%, according to research conducted by Pfizer.

European airline executives have long urged more consolidation Portugal has yet to formally launch TAP sale process IAG, Lufthansa, Air France-KLM have all expressed interest Last major airline ...